MORPHEUS8 MICRONEEDLING RF
The Morpheus8 is FDA approved, is a new subdermal adipose remodeling device (SARD) that fractionally remodels and contours the face and body. Penetrating deep into the skin and fat, this morphs the aging face or body into a more desired smooth and sleek appearance, for all skin tones. Morpheus8 helps improve and reduce the appearance of:
• Face and body scars
• Skin texture concerns, such as dilated pores
• Sun damage and fine wrinkles or line
• Mild facial sagging and mild jowls
The treatment is relatively painless even with the deeper penetration of needles. The needles used are very sharp and fine, allowing the benefit of puncturing your skin without the feeling of any tugging or pulling. To ensure your comfort, a topical cream will be applied to the treatment area. At the begining, you might feel a slight prickling sensation followed by a feeling of warmth as the needles pass over your skin.
For best results, Doctor recommends 3 treatments, spaced 6-8 weeks apart, for maximal anti-aging and rejuvenation results. Patients with acne scarring and stretchmarks may require 4-6 treatments. As every patient is different, sessions treatment will be based on your individual anatomy, health history, and aesthetic needs.
Since patient downtime is minimal, makeup can be applied 1 to 2 days after the treatment. Patients should expect to see micro lesions for a few days after treatment, swelling, some scratches and slight redness for up to 1 week depending on treatment parameters and can return to work the day after treatment.
Patients should moisturize the treatment area and avoid direct sun exposure. It is also recommended that patients use a good, broad spectrum sunscreen every day. In addition to reducing their future risk of skin cancer, sunscreens also reduce wrinkles and slow the aging process.
Visible results could start after one week, but typically after three weeks the most noticeable results appear. Improvements continue up to three months after treatment. Individuals results may vary.